GB0623381D0 - Use of a compound as VEGF inhibitor - Google Patents

Use of a compound as VEGF inhibitor

Info

Publication number
GB0623381D0
GB0623381D0 GBGB0623381.1A GB0623381A GB0623381D0 GB 0623381 D0 GB0623381 D0 GB 0623381D0 GB 0623381 A GB0623381 A GB 0623381A GB 0623381 D0 GB0623381 D0 GB 0623381D0
Authority
GB
United Kingdom
Prior art keywords
compound
vegf inhibitor
vegf
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0623381.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AcurePharma AB
Original Assignee
AcurePharma AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AcurePharma AB filed Critical AcurePharma AB
Priority to GBGB0623381.1A priority Critical patent/GB0623381D0/en
Publication of GB0623381D0 publication Critical patent/GB0623381D0/en
Priority to PCT/EP2007/009767 priority patent/WO2008061647A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
GBGB0623381.1A 2006-11-23 2006-11-23 Use of a compound as VEGF inhibitor Ceased GB0623381D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0623381.1A GB0623381D0 (en) 2006-11-23 2006-11-23 Use of a compound as VEGF inhibitor
PCT/EP2007/009767 WO2008061647A1 (en) 2006-11-23 2007-11-12 Use of a compound as vegf inhibitor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0623381.1A GB0623381D0 (en) 2006-11-23 2006-11-23 Use of a compound as VEGF inhibitor

Publications (1)

Publication Number Publication Date
GB0623381D0 true GB0623381D0 (en) 2007-01-03

Family

ID=37636386

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0623381.1A Ceased GB0623381D0 (en) 2006-11-23 2006-11-23 Use of a compound as VEGF inhibitor

Country Status (2)

Country Link
GB (1) GB0623381D0 (en)
WO (1) WO2008061647A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010108503A1 (en) 2009-03-24 2010-09-30 Life & Brain Gmbh Promotion of neuronal integration in neural stem cell grafts
RU2012106467A (en) * 2009-07-31 2013-09-10 Анамар Аб COMPOUNDS FOR TREATMENT OF INFLAMMATION
WO2016001389A1 (en) 2014-07-02 2016-01-07 Inflectis Bioscience Novel therapeutic uses of benzylideneguanidine derivatives for the treatment of proteopathies
SI3164391T1 (en) 2014-07-02 2019-12-31 InFlectis BioScience, O-alkyl-benzylideneguanidine derivatives and therapeutic use for the treatment of disorders associated an accumulation of misfolded proteins
WO2019215470A1 (en) 2018-05-09 2019-11-14 INSERM (Institut National de la Santé et de la Recherche Médicale) Use of guanabenz or derivates thereof for the treatment of type i ifn-dependent pathologies

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5599984A (en) * 1994-01-21 1997-02-04 The Picower Institute For Medical Research Guanylhydrazones and their use to treat inflammatory conditions
SE9604348D0 (en) * 1996-11-26 1996-11-26 Wapharm Ab Use of hydroxyguanidines
GB0019357D0 (en) * 2000-08-07 2000-09-27 Melacure Therapeutics Ab Novel phenyl guanidines

Also Published As

Publication number Publication date
WO2008061647A8 (en) 2008-11-27
WO2008061647A1 (en) 2008-05-29

Similar Documents

Publication Publication Date Title
GB0611405D0 (en) FKBP-L: A novel inhibitor of angiogenesis
PT2094708E (en) A pyrrolopyrazin as syk-kinase inhibitor
SI2402317T1 (en) DGAT inhibitor
PL2361922T3 (en) Intermediate to HCV-Nucleoside Inhibitors
SI2295410T1 (en) HDAC inhibitor
GB0621607D0 (en) Inhibitors of c-Met
HK1200440A1 (en) Crystalline forms of inhibitor
EP2011788A4 (en) Oxadiazolidinedione compound
IL196067A0 (en) New cxcr2 inhibitors
EP1985620A4 (en) 10a-AZALIDE COMPOUND
ZA200810025B (en) Cox-2 inhibitor
GB0602778D0 (en) Novel compound
HK1131127A1 (en) Binding inhibitor of sphingosine-1-phosphate
EP2050036A4 (en) Potentiation of antifungal compounds
EP2000469A4 (en) Acylaminopiperidine compound
GB0619325D0 (en) New compounds
GB0623381D0 (en) Use of a compound as VEGF inhibitor
IL205299A0 (en) Parp inhibitor compounds
EP2177529A4 (en) Novel -secretase inhibitor
EP2036894A4 (en) Aurora inhibitor
GB0604142D0 (en) Compound
EP2218719A4 (en) Abcg2 inhibitor
HK1102210A2 (en) A kind of mending -mouth of pole-charge
GB0625827D0 (en) New compounds
GB0625826D0 (en) New compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)